R. Streicher
University of Cologne
8 Papers
64 Citations
R. Streicher is an academic researcher from University of Cologne. The author has contributed to research in topics: Insulin receptor & Insulin. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
The organization of the human myelin basic protein gene. Comparison with the mouse gene.
R. Streicher,Wilhelm Stoffel +1 more
TL;DR: There is a high degree of conservation in the seven exons and the 5'-regulatory and part of the 3'-noncoding region: the nucleotide sequence of the coding region of the human and mouse gene show a 93% homology.
34
A single nucleotide substitution in the promoter region of the apolipoprotein C-II gene identified in individuals with chylomicronemia.
TL;DR: The pedigree analysis and experimental results are evidence that this is the first mutation in the apolipoprotein C-II gene where a single nucleotide substitution diminishes the binding of a transcription factor to a positive cis-acting clement in the promoter resulting in a depletion of apoC-II in plasma.
23
Molecular biology of insulin resistance.
TL;DR: It is outlined how the combination of both clinical medicine and molecular biology not only helps to understand insulin action and the pathogenesis of insulin resistance, but also leads to new avenues in the differential diagnosis, therapy, and possibly prevention of this heterogenous but most frequent metabolic and endocrine disorder.
17
Defects of insulin and IGF-1 action at receptor and postreceptor level in a patient with type A syndrome of insulin resistance.
Birgit Knebel,S. Kellner,Jorg Kotzka,Gerhard Siemeister,M. Dreyer,R. Streicher,Martina Schiller,H. W. Rüdiger,Eva Seemanova,Wilhelm Krone,Dirk Müller-Wieland +10 more
TL;DR: Evidence is provided that genetic syndromes of insulin resistance can be associated with both, receptor and postreceptor defects.
9
•Journal Article
Regulation of the LDL receptor gene expression by hormones.
TL;DR: Using the antisense technique, it is revealed that SREBP-1 is selectively involved in the signal transduction pathway of insulin and IGF-I.
7